Related Experiment Video
Updated: May 7, 2026
08:57
Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models
Published on: May 17, 2024
Primary mesenteric smooth muscle tumor: an entity with unpredictable biologic behavior.
Ioannis Kalogiannidis1, Thomas Stavrakis, Ioannis Amplianitis
13rd Department of Obstetrics & Gynecology, Aristotle University of Thessaloniki, Konstantinoupoleos 49, 54642 Thessaloniki, Greece.
Case Reports in Obstetrics and Gynecology
|September 25, 2013
Summary
Large smooth muscle tumors in the mesentery are rare and often aggressive, regardless of initial benign histologic appearance. This case highlights the need for vigilance and close follow-up for these unusual mesenteric tumors.
Area of Science:
- Gastroenterology
- Surgical Oncology
- Pathology
Background:
- Mesenteric smooth muscle tumors are rare neoplastic lesions.
- Their biologic behavior is often unpredictable and malignant, irrespective of histologic features.
- Accurate diagnosis and management are challenging due to rarity.
Purpose of the Study:
- To present a case of a large mesenteric smooth muscle tumor.
- To discuss the diagnostic and prognostic challenges associated with such tumors.
- To emphasize the importance of increased awareness and close follow-up.
Main Methods:
- Case presentation of a 48-year-old patient with a large mesenteric smooth muscle tumor.
- Surgical excision of the tumor.
- Histopathologic examination to determine tumor characteristics.
- Clinical follow-up to assess outcomes.
Main Results:
- A large smooth muscle tumor was surgically excised from the mesentery.
- Histopathology revealed a benign-appearing smooth muscle tumor.
- The patient had an uneventful postoperative recovery.
- Nine-month follow-up showed no evidence of recurrent disease.
Conclusions:
- Large mesenteric smooth muscle tumors require increased clinical awareness.
- Even tumors with indolent histologic features can exhibit aggressive behavior.
- Close follow-up is crucial for patients with mesenteric smooth muscle tumors, regardless of initial appearance.
